TRVI earnings
Trevi Therapeutics (TRVI) next earnings date and estimates, and its past reports: EPS against estimates, the surprise and revenue.
TRVI earnings history
| Quarter | Reported | EPS | Estimate | Surprise | Revenue |
|---|---|---|---|---|---|
| Q2 2026 | Aug 6, 2026 | -0.11 | -0.11 | -0.49% | – |
| Q1 2026 | May 5, 2026 | -0.09 | -0.07 | -28.57% | – |
| Q4 2025 | Mar 17, 2026 | -0.06 | -0.10 | 40.00% | – |
| Q3 2025 | Nov 13, 2025 | -0.08 | -0.10 | 20.00% | – |
| Q2 2025 | Aug 7, 2025 | -0.09 | -0.10 | 10.00% | – |
| Q1 2025 | May 8, 2025 | -0.09 | -0.13 | 30.77% | – |
| Q4 2024 | Mar 18, 2025 | -0.11 | -0.12 | 8.33% | – |
| Q3 2024 | Nov 6, 2024 | -0.13 | -0.12 | -8.33% | – |
| Q2 2024 | Aug 8, 2024 | -0.12 | -0.11 | -9.09% | – |
| Q1 2024 | May 7, 2024 | -0.11 | -0.09 | -22.22% | – |
| Q4 2023 | Mar 20, 2024 | -0.08 | -0.10 | 20.00% | – |
| Q3 2023 | Nov 9, 2023 | -0.08 | -0.09 | 11.11% | – |
| Aug 10, 2023 | -0.07 | -0.09 | 22.22% | – | |
| May 11, 2023 | -0.06 | -0.08 | 25.00% | – | |
| Mar 16, 2023 | -0.06 | -0.11 | 45.45% | – | |
| Nov 10, 2022 | -0.12 | -0.15 | 20.00% | – | |
| Aug 11, 2022 | -0.14 | -0.21 | 33.33% | – | |
| May 12, 2022 | -0.24 | -0.31 | 22.58% | – | |
| Mar 17, 2022 | -0.28 | -0.34 | 17.65% | – | |
| Nov 10, 2021 | -0.34 | -0.33 | -3.03% | – |
- TRVI reports next on Nov 12, 2026, with EPS of -0.14 expected.
- TRVI beat EPS estimates in 19 of its last 30 reports.
Updated 2026-11-02 23:14 UTC